Position in LGND
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,340,120
+$613,045 QoQ
Shares Held
56,800
+0.1% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 45.985915492957744.ToString("F0")%
Shared 0.ToString("F0")%
None 54.01408450704225.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. LGND ranks #24 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,340,120 | 56,800 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $10,727,075 | 56,736 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,526,013 | 59,422 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,764,869 | 59,508 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,040,923 | 57,456 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $6,369,531 | 59,445 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $6,007,401 | 60,020 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,167,834 | 61,332 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,404,640 | 60,255 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,251,275 | 59,525 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,423,049 | 57,127 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,001,477 | 55,499 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,901,695 | 53,041 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,386,693 | 50,699 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,605,699 | 48,507 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,662,906 | 47,844 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,229,930 | 46,027 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,336,345 | 45,003 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,016,290 | 46,211 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,142,919 | 50,622 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,328,608 | 45,515 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,841,799 | 45,806 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,722,833 | 45,790 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,815,877 | 54,688 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,830,043 | 62,384 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||